|
ALIM
|
Alimera Sciences, Inc.
|
US
|
NASDAQ
|
|
AMPE
|
Ampio Pharmaceuticals, Inc.
|
US
|
AMEX
|
|
EYPT
|
EyePoint Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
GRAY
|
Graybug Vision, Inc.
|
US
|
NASDAQ
|
|
KALV
|
KalVista Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
OCUP
|
Ocuphire Pharma, Inc.
|
US
|
NASDAQ
|
|
OPT
|
Opthea Limited
|
US
|
NASDAQ
|
|
RZLT
|
Rezolute, Inc.
|
US
|
NASDAQ
|
|
VERS
|
ProShares Metaverse ETF
|
US
|
AMEX
|
|
KBBTF
|
Kubota Pharmaceutical Hldgs CO Ltd
|
US
|
OTC
|
|
KHTRF
|
Knight Therapeutics
|
US
|
OTC
|
|
MLLCF
|
Molecular Partners Ag
|
US
|
OTC
|
|
OXUR
|
Oxurion NV
|
BE
|
BR
|
|
9995
|
Remegen Co Ltd
|
HK
|
HK
|
|
068270
|
Celltrion Inc
|
KR
|
KO
|
|
XBRANE
|
Xbrane Biopharma AB
|
SE
|
ST
|
|
688177
|
Bio-Thera Solutions Ltd
|
CN
|
SHG
|
|
MOLN
|
Molecular Partners AG
|
CH
|
SW
|